Seres Therapeutics Inc
NASDAQ:MCRB

Watchlist Manager
Seres Therapeutics Inc Logo
Seres Therapeutics Inc
NASDAQ:MCRB
Watchlist
Price: 0.9155 USD -0.59% Market Closed
Market Cap: 156.3m USD
Have any thoughts about
Seres Therapeutics Inc?
Write Note

Wall Street
Price Targets

MCRB Price Targets Summary
Seres Therapeutics Inc

Wall Street analysts forecast MCRB stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for MCRB is 3.9515 USD with a low forecast of 1.01 USD and a high forecast of 10.5 USD.

Lowest
Price Target
1.01 USD
10% Upside
Average
Price Target
3.9515 USD
332% Upside
Highest
Price Target
10.5 USD
1 047% Upside

MCRB Last Price Targets
Seres Therapeutics Inc

The latest public price target was made on Jun 7, 2024 by Keay Nakae from Chardan Capital , who expects MCRB stock to rise by 37% over the next 12 months. You can read more about this price target by viewing the article on TheFly.

Analyst Price Target Date Article
Keay Nakae
Chardan Capital
1.25 USD
Upside 37%
6 months ago
Jun 7, 2024
Seres Therapeutics price target lowered to $1.25 from $6 at Chardan
TheFly
Keay Nakae
Chardan Capital
Price Target 1.25 USD
Upside/Downside 37%
View Source
Seres Therapeutics Inc Competitors:
Price Targets
MIRM
Mirum Pharmaceuticals Inc
54% Upside
LEGN
Legend Biotech Corp
147% Upside
REGN
Regeneron Pharmaceuticals Inc
58% Upside
FYB
Formycon AG
80% Upside
6160
Beigene Ltd
27% Upside
358570
GI Innovation Inc
202% Upside
CDMO
Avid Bioservices Inc
4% Upside
BMRN
Biomarin Pharmaceutical Inc
51% Upside

Revenue
Forecast

Revenue Estimate
Seres Therapeutics Inc

The compound annual growth rate of Seres Therapeutics Inc's revenue for the next 4 years is -16%.

N/A
Past Growth
-16%
Estimated Growth
Estimates Accuracy
-1%
Average Miss

Operating Income
Forecast

Operating Income Estimate
Seres Therapeutics Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-2%
Average Miss

Net Income
Forecast

Net Income Estimate
Seres Therapeutics Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-68%
Average Miss

See Also

Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is MCRB's stock price target?
Price Target
3.9515 USD

According to Wall Street analysts, the average 1-year price target for MCRB is 3.9515 USD with a low forecast of 1.01 USD and a high forecast of 10.5 USD.

What is Seres Therapeutics Inc's Revenue forecast?
Projected CAGR
-16%

The compound annual growth rate of Seres Therapeutics Inc's revenue for the next 4 years is -16%.

Back to Top